These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2768812)

  • 1. Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects.
    Grzanna R; Berger U; Fritschy JM; Geffard M
    J Histochem Cytochem; 1989 Sep; 37(9):1435-42. PubMed ID: 2768812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
    Fritschy JM; Grzanna R
    J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of DSP-4 on noradrenaline axons in cerebral cortex and hypothalamus may reflect heterogeneity of noradrenaline uptake sites.
    Zaczek R; Fritschy JM; Culp S; De Souza EB; Grzanna R
    Brain Res; 1990 Jul; 522(2):308-14. PubMed ID: 2171719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase.
    Fritschy JM; Geffard M; Grzanna R
    J Chem Neuroanat; 1990; 3(4):309-21. PubMed ID: 2204356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats.
    Logue MP; Growdon JH; Coviella IL; Wurtman RJ
    Life Sci; 1985 Aug; 37(5):403-9. PubMed ID: 4021721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.
    Zhang X; Zuo DM; Davis BA; Boulton AA; Yu PH
    J Neurosci Res; 1996 Feb; 43(4):482-9. PubMed ID: 8699534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord.
    Lyons WE; Fritschy JM; Grzanna R
    J Neurosci; 1989 May; 9(5):1481-9. PubMed ID: 2542474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 potentiates the long-term effect of parachloroamphetamine on 5-hydroxytryptamine metabolism in the rat.
    Eller M; Harro J
    Neurosci Lett; 2002 Mar; 322(1):53-6. PubMed ID: 11958842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning.
    Heal DJ; Butler SA; Prow MR; Buckett WR
    Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSP-4 treatment produces abnormal tyrosine hydroxylase immunoreactive fibers in rat hippocampus.
    Booze RM; Hall JA; Cress NM; Miller GD; Davis JN
    Exp Neurol; 1988 Jul; 101(1):75-86. PubMed ID: 2899031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy.
    Giorgi FS; Mauceli G; Blandini F; Ruggieri S; Paparelli A; Murri L; Fornai F
    Epilepsia; 2006; 47 Suppl 5():21-5. PubMed ID: 17239101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
    Harro J; Jossan SS; Oreland L
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
    Radwanska K; Nikolaev E; Kaczmarek L
    Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DSP-4-induced depletion of brain norepinephrine on appetitive and aversive memory retrieval.
    Kumar KB; Karanth KS
    Indian J Exp Biol; 1994 Oct; 32(10):724-8. PubMed ID: 7821983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimentally-induced neuron loss in the locus coeruleus of adult rats.
    Fritschy JM; Grzanna R
    Exp Neurol; 1991 Jan; 111(1):123-7. PubMed ID: 1984427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
    Nowak P
    Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic effects of DSP-4 on the central noradrenergic system in male zebra finches.
    Waterman SA; Harding CF
    Behav Brain Res; 2008 Apr; 188(2):271-80. PubMed ID: 18160108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma.
    Jones MD; Hess EJ
    Pharmacol Biochem Behav; 2003 Apr; 75(1):209-16. PubMed ID: 12759129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.